Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Meticulous determination of the time since death (TSD) is critical in certain criminal investigations. This study aimed to identify optimal markers for TSD estimation and develop a mathematical model applicable under varying conditions. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and β-Actin (ACTB) mRNA levels were analyzed in 10 human skeletal muscle samples using real-time quantitative PCR at eight time intervals (6, 12, 18, 24, 30, 36, 42, and 48 h) within 48 h postmortem at 25°C. Among the candidate markers, GAPDH demonstrated the strongest correlation with times since death. At the same time, ACTB expression remained comparatively stable across all samples and time points as identified by RefFinder (reference gene analysis tool). Mathematical equations were developed using the C values for GAPDH, ACTB, and ΔC (GAPDH-ACTB) and the cubic model gave the highest determination of coefficient while the error rates were low in the quadratic model. The findings indicate that ACTB is an optimal marker for estimating TSD within the 30 to 36-h postmortem interval, while GAPDH is more suitable for the 36 to 48-h period.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ca.70026DOI Listing

Publication Analysis

Top Keywords

time death
8
gapdh actb
8
human skeletal
8
skeletal muscle
8
time
5
gapdh
5
actb
5
death estimation
4
estimation mrna
4
mrna expression
4

Similar Publications

Cardiovascular diseases (CVDs) remain a leading cause of death, particularly in developing countries, where their incidence continues to rise. Traditional CVD diagnostic methods are often time-consuming and inconvenient, necessitating more efficient alternatives. Rapid and accurate measurement of cardiac biomarkers released into body fluids is critical for early detection, timely intervention, and improved patient outcomes.

View Article and Find Full Text PDF

IL12-based phototherapeutic nanoparticles through remodeling tumor-associated macrophages combined with immunogenic tumor cell death for synergistic cancer immunotherapy.

Biomater Sci

September 2025

Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, The Tianjin Key Laboratory of Biomaterials, Institute of Biomedical Engineering, Peking Union Medical College & Chinese Academy of Medical Sciences, Tianjin, 300192, China.

Various cancer therapeutic strategies have been designed for targeting tumor-associated macrophages (TAMs), but TAM reprogramming-based monotherapy is often clinically hindered, likely due to the lack of a coordinated platform to initiate T cell-mediated immunity. Herein, we fabricated reactive oxygen species (ROS)-responsive human serum albumin (HSA)-based nanoparticles (PEG/IL12-IA NPs) consisting of indocyanine green (ICG), arginine (Arg), and interleukin 12 (IL12). Upon laser irradiation, the nanoparticles were found to be able to dissociate, thus facilitating the release of IL12.

View Article and Find Full Text PDF

Background: Distal triceps tendon rupture is related to high complication rates with up to 25% failures. Elbow stiffness is another severe complication, as the traditional approach considers prolonged immobilization to ensure tendon healing. Recently, a dynamic tape was designed, implementing a silicone-infused core for braid shortening and preventing repair elongation during mobilization, thus maintaining constant tissue approximation.

View Article and Find Full Text PDF

Ischemic stroke (IS) has high morbidity/mortality with limited treatments. This study screened core copper homeostasis-related genes in IS and validated their function as precise intervention targets. Human IS gene chip data were retrieved from GEO, and copper homeostasis genes from multiple databases.

View Article and Find Full Text PDF

Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary intervention.

Clin Res Cardiol

September 2025

Department of Cardiology, University Heart Center, University Hospital Zurich, Center for Translational and Experimental Cardiology (CTEC), University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.

Background: Diabetic patients with ST-segment elevation myocardial infarction (STEMI) are at an increased risk of cardiovascular events as compared to non-diabetic patients. This analysis investigated outcomes of diabetic patients presenting with multivessel disease (MVD) and STEMI in a contemporary trial and the relevance of an immediate versus staged multivessel PCI strategy in this high-risk population.

Methods: Patients enrolled in the MULTISTARS AMI trial were stratified according to the presence/absence of diabetes.

View Article and Find Full Text PDF